IRB Number:

07-005798

Trial Status:

Open for Enrollment

Phase: I

Why is this study being done?

The purpose of this study is to look for genes that are the cause of epilepsy and to look for genes that have an impact on the effectiveness of over the counter and prescription medicines used to treat epilepsy.

Who is Eligible to Participate in the Study?

Participants must have epilepsy and have a sibling with epilepsy, OR, have specific epilepsy dx of: infantile spasms, lennox gastaut syndrome, periventricular nodular heterotopia, OR polymicrogyria and have both parents available to participate in the blood draw and questionnaire.

Maximum Age:

60

What is Involved With this Study?

Participants will have 2 vials of blood drawn and will be asked to complete a set of detailed questionnaires (demographics, medical history information, etc.)

How long will the Study run?

Participation will require a one time visit, which will last approximately 2-3 hours. Then, approximately one year after participation, phone contact will be made to complete a follow-up questionnaire that will last approximately 1/2 hour.

Who can I Contact for Additional Information on this Trial?

Sherry Klingerman, Study Coordinator - Rochester
(klingerman.sherry@mayo.edu)

Riann Boyd, Study Coordinator - Florida
(boyd.riann@mayo.edu)

Brandy Maschhaupt, Study Coordinator - Arizona
(maschhaupt.brandy@mayo.edu)

Dr. Gregory Cascino, Principal Investigator
(cascino.gregory@mayo.edu)

What is/are the Locations of this Clinical Trial?

• Rochester, MN
• Jacksonville, FL
• Scottsdale and Phoenix, AZ

Last updated: 11/25/2009